1-6 of 6
Ruben Niesvizky, M.D.
Close
Sort by
Journal Articles

Lenalidomide Targets Myeloma Cells Preferentially During Prolonged Early G1 Arrest but Not Synchronization Into S Phase by Selective and Reversible Inhibition of CDK4/CDK6 through Loss of IRF-4

Xiangao Huang, Ph.D., Maurizio Di Liberto, Ph.D., David Jayabalan, B.S.M.S, Mohamad Hussein, M.D., Sophia Randolph, M.D., Ph.D., Ruben Niesvizky, M.D., Selina Chen-Kiang, Ph.D.
Journal: Blood
Blood (2010) 116 (21): 449.
https://doi.org/10.1182/blood.V116.21.449.449
Published: 2010
Journal Articles

Induction of Metabolic Impairment In Prolonged Early G1 Arrest Induced by CDK4/CDK6 Inhibition Sensitizes Myeloma Cells for Proteasome Inhibitor Killing During Subsequent S Phase Synchronization

Maurizio Di Liberto, Ph.D., Xiangao Huang, Ph.D., Jamieson Bretz, Ph.D., Scott A Ely, M.D., Rediet Zewdu, B.S., David Jayabalan, B.S.M.S, Suzhen Chen, B.S., Christopher J Kirk, Ph.D., Sophia Randolph, M.D., Ph.D., Ruben Niesvizky, M.D., Ph.D., Selina Chen-Kiang, Ph.D.
Journal: Blood
Blood (2010) 116 (21): 2989.
https://doi.org/10.1182/blood.V116.21.2989.2989
Published: 2010
Journal Articles

Selective Inhibition of CDK4 and CDK6 Primes Chemoresistant MCL Cells for Killing by Proteasome Inhibitor Bortezomib by Activating Cell Cycle-Coupled Apoptosis

Maurizio Di Li berto, Ph.D., Xiangao Huang, Ph.D., Amy Chadburn, M.D., Peter Martin, M.D., Ruben Niesvizky, M.D., Scott Ely, M.D., M.P.H., John P. Leonard, M.D., Selina Chen- Kiang, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 3624.
https://doi.org/10.1182/blood.V112.11.3624.3624
Published: 2008
Journal Articles

Targeting Cdk4/6 in Combination Therapy Overcomes Proteasome Inhibitor Resistance in Multiple Myeloma through Synergistic Mitochondria Depolarization.

Xiangao Huang, PhD, Tracey Louie, B.Sc., Maurizio Di Liberto, Ph.D., Jun Rice, Ph.D., David Jayabalan, B.Sc., Kang Zhang, B.Sc., Michael Palladino, Ph.D., Isan Chen, M.D., Peter Toogood, Ph.D, Ruben Niesvizky, M.D., Malcolm A.S. Moore, Ph.D., Selina Chen-Kiang, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 667.
https://doi.org/10.1182/blood.V110.11.667.667
Published: 2007
Journal Articles

TOP-M Chemotherapy (Thiotepa, Oncovin [Vincristine], Prednisone, Mitoxantrone) Plus Rituximab for Marginal Zone Lymphoma.

Morton Coleman, M.D., Richard R. Furman, M.D, Ruben Niesvizky, M.D., Michelle Ashe, Lena Mathews, Jennifer Fiore, Jamie Ketas, John P. Leonard
Journal: Blood
Blood (2004) 104 (11): 4600.
https://doi.org/10.1182/blood.V104.11.4600.4600
Published: 2004
Journal Articles

Periocular MALT Lymphomas (Conjunctival/Orbital): Complete Responses with Antibiotic Therapy.

Morton Coleman, M.D., John P. Leonard, M.D., Jules Decter, M.D., Richard R. Furman, M.D., Ruben Niesvizky, M.D., Indira Rollins, David H. Abramson, M.D.
Journal: Blood
Blood (2004) 104 (11): 2493.
https://doi.org/10.1182/blood.V104.11.2493.2493
Published: 2004